Efrat Shavit Stein

Title: Efrat Shavit Stein: Innovator in Peptide Research

Introduction

Efrat Shavit Stein is a notable inventor based in Karkur, Israel. She has made significant contributions to the field of peptide research, particularly in the area of inflammation treatment. With a focus on innovative solutions, her work has the potential to impact medical therapies significantly.

Latest Patents

Efrat holds 1 patent for her invention titled "Peptides that inhibit binding of EPCR to its ligand to treat inflammation." This patent discloses an isolated peptide of up to 6 amino acids that comprises an amino acid sequence inhibiting the binding of an endothelial cell protein C receptor (EPCR) ligand to the EPCR. Additionally, the patent includes a description of a modified peptide and a molecule that incorporates an amino acid sequence inhibiting the EPCR ligand binding, attached to a heterologous moiety. The patent also covers pharmaceutical compositions and methods of treatment related to these peptides.

Career Highlights

Efrat is currently associated with Tel Hashomer Medical Research Infrastructure and Services Ltd., where she continues her research and development efforts. Her work is characterized by a commitment to advancing medical science through innovative peptide applications.

Collaborations

Efrat has collaborated with notable colleagues, including Joab Chapman and Nicola Maggio, who contribute to her research endeavors. Their combined expertise enhances the potential impact of their work in the medical field.

Conclusion

Efrat Shavit Stein's contributions to peptide research exemplify the innovative spirit of modern science. Her patent on peptides that inhibit EPCR binding showcases her dedication to addressing critical health issues. Through her work, she is paving the way for new therapeutic approaches to inflammation treatment.